Adipocyte nuclei captured from VAT and SAT by unknown
TECHNICAL ADVANCE Open Access
Adipocyte nuclei captured from VAT
and SAT
Suresh Ambati1, Ping Yu1, Elizabeth C. McKinney1, Muthugapatti K. Kandasamy1, Diane Hartzell2,3,
Clifton A. Baile2,3ˆ and Richard B. Meagher1*
Abstract
Background: Obesity-related comorbidities are thought to result from the reprogramming of the epigenome in
numerous tissues and cell types, and in particular, mature adipocytes within visceral and subcutaneous adipose
tissue, VAT and SAT. The cell-type specific chromatin remodeling of mature adipocytes within VAT and SAT is
poorly understood, in part, because of the difficulties of isolating and manipulating large fragile mature adipocyte
cells from adipose tissues.
Methods: We constructed MA-INTACT (Mature Adipocyte-Isolation of Nuclei TAgged in specific Cell Types) mice using
the adiponectin (ADIPOQ) promoter (ADNp) to tag the surface of mature adipocyte nuclei with a reporter protein. The
SUN1mRFP1Flag reporter is comprised of a fragment of the nuclear transmembrane protein SUN1, the fluorescent
protein mRFP1, and three copies of the Flag epitope tag.
Results: Mature adipocyte nuclei were rapidly and efficiently immuno-captured from VAT and SAT (MVA and MSA
nuclei, respectively), of MA-INTACT mice. MVA and MSA nuclei contained 1,000 to 10,000-fold higher levels of
adipocyte-specific transcripts, ADIPOQ, PPARg2, EDNRB, and LEP, relative to uncaptured nuclei, while the latter expressed
higher levels of leukocyte and endothelial cell markers IKZF1, RETN, SERPINF1, SERPINE1, ILF3, and TNFA. MVA and MSA
nuclei differentially expressed several factors linked to adipogenesis or obesity-related health risks including CEBPA,
KLF2, RETN, SERPINE1, and TNFA. The various nuclear populations dramatically differentially expressed transcripts
encoding chromatin remodeler proteins regulating DNA cytosine methylation and hydroxymethylation (TETs, DNMTs,
TDG, GADD45s) and nucleosomal histone modification (ARID1A, KAT2B, KDM4A, PRMT1, PRMT5, PAXIP1). Remarkably, MSA
and MVA nuclei expressed 200 to 1000-fold higher levels of thermogenic marker transcripts PRDM16 and UCP1.
Conclusions: The MA-INTACT mouse enables a simple way to perform cell-type specific analysis of highly purified
mature adipocyte nuclei from VAT and SAT and increases the statistical significance of data collected on adipocytes.
Isolated VAT and SAT adipocyte nuclei expressed distinct patterns of transcripts encoding chromatin remodeling
factors and proteins relevant to diabetes, cardiovascular disease, and thermogenesis. The MA-INTACT mouse is an
useful model to test the impact of caloric intake, dietary nutrients, exercise, and pharmaceuticals on the
epigenome-induced health risks of obesity.
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Introduction
Subcutaneous and visceral adipose tissues, SAT and VAT,
become the dominant endocrine organs in obese individ-
uals [1–3]. Increased VAT is linked to insulin resistance,
diabetes, hypertension, atherosclerosis, and increased hep-
atic fat content [4, 5]. By contrast, obese SAT continues to
respond better to insulin and is not as clearly linked to
disease. Mature adipocytes (MAs) within SAT and VAT,
MSAs and MVAs, respectively, have different develop-
mental histories, distinct programs of gene expression,
and dissimilar profiles of endocrine secretion [6–10].
MVAs and MSAs contribute distinctly to increased health
risk due to altered metabolic properties and changes in
adipokine secretion [11–14]. In general, when compared
to tissue form normal weight individuals, obese VAT in
particular and to a lesser extent obese SAT secrete harm-
fully higher levels of angiotensin, TNFα, IL1B, SERPINE1-
1, and LEP as well as lower levels of generally beneficial
IL10, ADIPOQ, omentin, APLN, and visfatin [15–19].
Therefore, VAT derived obese MVAs are more pathogenic
[4]. Beige adipocytes in SAT, which are metabolically
beneficial in normal weight individuals, become much less
active with obesity and aging [20–22]. Not only does the
number of MAs in VAT and SAT increase with obesity,
but the cells themselves become significantly enlarged.
Obese MAs promote inflammation, recruit macrophages,
and predispose obese individuals to health risks, including
the increased occurrence of cardiovascular disease, cancer,
and diabetes [4, 23–25]. Hence, there has been intense
interest in recent years in understanding the role of MAs
in obesity-related comorbidities.
Epigenetics is by its origin the study of cell-type spe-
cific differences [26–31]. While cell type specificity may
be the mantra of epigenetic analyses, few studies are per-
formed at the cell-type specific level despite data show-
ing the statistical significance of working at this level. As
an example of the importance of performing cell-type
specific analyses, among the seven major classes of per-
ipheral blood leukocyte types in healthy human subjects,
the two most similar (CD4 and CD8 T cells) and the two
most dissimilar (CD8 and eosinophils) white blood cell
types differ at 45,000 (9 %) and 190,000 (40 %), respect-
ively, of 475,000 DNA 5´-methylcytosine (5mC) residues
at informative CG dinucleotide sites [32]. Hence “whole
blood methylation results might be unintelligible” be-
cause the data represent the weighted average of cell
type differences. In addition, disease-related stress may
cause the reprogramming of hundreds of 5mC sites
within a single cell type [33, 34]. Studies of systemic
lupus erythematosus (SLE) identified hundreds of 5mC
sites in CD4+ T cells associated with the disease pheno-
type with median p values of ~10−7, while median p values
of ~10−3 were found associated with SLE when DNA from
the whole blood leukocyte fraction was examined [33, 35].
In short, the extra effort involved in examining enriched
cell-type specific populations from a tissue may be
expected to produce dramatically more meaningful
epigenetic data [32].
While there is little reason to doubt that epigenetic
reprogramming of obese adipocytes within their tissue
context is an important component of disease risk
[36–43], there are considerable challenges to perform-
ing cell-type specific epigenetic analysis of tissue-
derived MAs. Adipose tissues comprise a complex
mixture of cells including adipocytes, diverse endothe-
lial cells and leukocytes, and various multipotent pro-
genitor cell types. Obese SAT and VAT may have an
additional bias in the weighted average of cell types,
because the number of inflammatory leukocyte cell
types may increase several-fold over that found in the
tissue of normal weight individuals [44–46]. Another
bias may be introduced during cell isolations. MAs are
extremely large often ranging from 50 to 120 microns
in diameter, generally having a single lipid droplet.
They may be enzymatically dissociated and enriched
by floatation away from other cell types [47], but they
are still difficult to isolate and manipulate efficiently
due to their fragile structures and tendency to lyse rap-
idly with handling or while sitting on ice. Even larger
MA cell sizes are observed in obese VAT and SAT,
which inherently exacerbates problems of cell manipu-
lation. By contrast, various classes of multipotent and
progenitor adipose tissue derived stem cells (ADSCs)
and dedifferentiated adipocyte-derived progeny cells
(DFAT cells) may be isolated intact and viable from
SAT and VAT, in part, because they are small (15 to 25
microns) and relatively stable cells [48–51]. In short
the physiology of adipocytes does not favor their isola-
tion relative to other cells in VAT and SAT.
Herein, addresses the problem of cell-type specific
analysis of chromatin structure in MAs by applying
INTACT technology (isolation of nuclei tagged in
specific cell types) to MAs in a transgenic mouse
model. INTACT has been used to isolate nuclei from
specific cell types tagged in transgenic Arabidopsis
thaliana, Caenorhabditis elegans, and Drosophila mel-
anogaster [28, 52–54]. We developed a protocol that
simplifies the isolation of cellular nuclei from VAT, SAT,
and BAT. We screened for Nuclear membrane Targeted
Fusion proteins (NTFs), which when expressed from an
adiponectin derived promoter (ADNp), delivered both a
fluorescent reporter and epitope tags to the exterior
surface of MA nuclei. Our strategy for constructing a
MA-INTACT mouse is outlined in Fig. 1. MA nuclei from
transgenic mice expressing ADNp::SUN1mRFP1Flag are
highly enriched after capture on immuno-paramagnetic
beads. Captured and uncaptured classes of SAT and
VAT nuclei differentially expressed many of the
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expected cell type markers, but expressed distinctly dif-




Anti-RFP (ab34771), Anti-Flag (ab106259), anti-CD4
(ab846) antibodies were obtained from Abcam. Anti-
mRFP1 rabbit polyclonal antibody (rab pAb) was pre-
pared by Thermo Scientific Pierce Antibodies using their
2 Rabbit, 90 Day Protocol. We expressed the 672 bp
mRFP1 CDS with a C-Terminal 6xhis tag in E. coli from
the PET15b vector. After IPTG induction the protein
levels were very high and the cells turned red. The red
protein was highly enriched on a column with nickel
charged resin, Ni-NTA Superflow (Qiagen 30410). The
IgG fraction of anti-mRFP1 antibody was enriched by
ammonium sulfate fractionation [55] and dialyzed in
phosphate buffered saline (10 mM H2NaPO4/HNa2PO4
pH = 7.4, 150 mM NaCl, 0.1 % sodium azide) for storage
at 4 °C.
NTF fusion proteins to tag adipocyte nuclei
An adiponectin promoted vector plasmid pADNpcDNA3.1
KanR was constructed to drive NTF expression in MAs
(Additional file 1: Figures S1, Additional file 2: Figure S2).
Four constructs were made from three NTFs with the po-
tential to tag the surface of adipocyte nuclei with an
Fig. 1 Strategy for implementing INTACT to capture adipocyte nuclei. a The ADNp::SUN1mRFP1Flag gene construct. This promoter is a truncated
5.4 kb version of the mouse adiponectin promoter (ADNp) modified slightly from one described previously [63]. This promoter was fused first to
the N-terminal portion of mouse SUN1, then via a flexible linker peptide to the enhanced red fluorescent protein mRFP1, which was fused in
frame through a linker peptide to a epitope Flag tag containing three distinct Flag sequences (3xFlag). The ADIPOQ promoter region contains a
5´ upsteam exon (yellow) and intron, a 5´ mRNA UTR, and the ATG start codon. The 3´ UTR and poly(A) addition site are from SV40 in the
pcDNA3.1 vector. More detailed maps are shown in Additional file 1: Figure S1 and Additional file 3: Figure S3. b Proposed deposition of the
SUN1mRFP1Flag protein tethered to the inner nuclear membrane and tagging the exterior of the nucleus. c Diagram of adipose tissue comprised of
MAs expressing the SUN1mRFP1Flag tag and many non-target cell types (progenitor cells, leukocytes, endothelial cells). d Capture and enrichment of
MA nuclei away from other cellular nuclei on paramagnetic beads labeled with anti-mRFP1, anti-GFP or anti-Flag. A total of four constructs designed
from 3 nuclear transmembrane proteins were examined (Table 1)
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epitope(s) to be used in immuno-capture experiments
(Additional file 3: Figure S3, Additional file 4: Figure S4,
Additional file 5: Figure S5, Additional file 6: Figure S6).
All three proteins are anchored via N-terminal domains fa-
cing into the nucleoplasm and C-terminal domains facing
outward toward the cytoplasm. Mouse SUN1 makes three
passes through the inner nuclear membrane. One con-
struct, SUN1mRFP1Flag, was made by fusing the N-
terminus of mRFP1 and a triple Flag tag to the C-terminal
end of a SUN1 N-terminal fragment (i.e., lacking the nor-
mal SUN1 C-terminus). Mouse Nesprin-3 (Nesp3) makes
one pass through the outer nuclear membrane. Two con-
structs were made based on Nesp3. The first,
Nesp3mRFP1Flag, is a simple fusion of mRFP1 and 3XFlag
domain from SUN1mRFP1Flag to the C-terminus of an N-
Terminal Nesp3 fragment (i.e., lacking the normal C-
terminus of Nesp3). Because the C-terminus of Nesp3 has
been implicated in its localization we made a second
construct. In Nesp3mRFP1Nesp, we added the C-terminal
domain of Nesp3 to the end of mRFP1, replacing the
3XFlag sequence in Nesp3mRFP1Flag. In each of the three
above constructs, (GlySer)4-5Gly linkers separate the differ-
ent domains. Arabidopsis RANGAP1 associates with the
cytoplasmic side of the nuclear pore complex. We used the
same RANGAP1GFP reporter sequence that was used in
the first successful report of INTACT technology in Arabi-
dopsis [28]. All four constructs were inserted into the adi-
ponectin expression vector. Construct sequences will be
available at NCBI’s sequence repository (DDBJ/EMBL/
Genbank - INSDC) once this manuscript is accepted for
publication.
Cell culture
Mouse embryo fibroblast cell line (3T3-L1, ATCC
#CL-173) was purchased from American Type Culture
Collection (Manassas, VA). Cells were cultured in
DMEM (Invitrogen #12800017) containing 10 %
bovine calf serum (Life Technologies, #16170078),
1 % penicillin-streptomycin-glutamine (Life Technolo-
gies, #10378016) and 1 % (v/v) 100 mM sodium pyru-
vate (Life Technologies, #11360070) at 37 °C in 95 %
air-5 % CO2.
Nucleofection
3T3-L1 preadipocytes (2 × 106 cells) were nucleofected
with each construct (0.1, 0.5, 1, and 2 ug DNA) using
the Amaxa Cell Line Nucleofector Kit V (Lonza #VCA-
1003). Each nucleofection was seeded into a 6 well mi-
crotiter plate in calf serum medium and expanded for
6 days with700 ug of neomycin G418 (Invitrogen
#10131035). Cells were transferred to 50 mm petri plates
and grown. Two days after reaching confluence, cells
were induced to differentiate for two days with DMEM
media containing 10 % fetal bovine serum (FBS) (Life
Technologies, #10437028), 0.5 μM 3-isobutyl-1-methyl-
xanthine (IBMX, Sigma #I5879), 1 μM dexamethasone
(Sigma #D4902) and 167 nM insulin (Sigma #I-6634).
Cells were maintained for the next two days in DMEM
medium containing 10 % FBS and 167 nM insulin. Cells
were cultured for an additional 4 days in 10 % FBS/
DMEM medium, during which time they differentiated
into MAs filled with lipid-droplets. MAs were main-
tained in 10 % FBS/DMEM medium and analyzed daily
for green or red fluorescent protein expression by fluor-
escence microscopy (FM) on Nikon (Eclipse TE2000-S)
inverted microscope.
Transgenic MA-INTACT mice expressing SUN1mRFP1Flag
nuclear tag in MAs
A 12.4 kb NotI fragment from our plasmid vector contain-
ing ADNp::SUN1mRFP1Flag reporter sequence (Additional
file 1: Figure S1 & Additional file 3: Figure S3) was used to
construct transgenic (Tg) mice in the C57 Black 6 (C57BL/
6 N) background. Among the mice identified with the
randomly integrated transgene, four mice expressed
SUN1mRFP1Flag mRNA in tail snip mRNA preparations
(Additional file 7: Figure S8). We identified two founding
mice, C023 and D025 (C and D lines), whose offspring
expressed significant amounts of the SUN1mRFP1Flag
mRNA in BAT, VAT, and SAT. We generated two inbred
mouse colonies, C023 and D025, homozygous for the
transgene. Both appear healthy and long-lived. The studies
reported herein represent data from hemizygous F2 and F3
generation animals used in breeding.
Enrichment of nuclei
The following rapid protocol for isolating adipose tissue
cellular nuclei or nuclei from transfected 3T3-L1 cells
follows closely to that which we published recently for
brain cell nuclei [30] (Additional file 8: Figure S7).
Freshly dissected and minced mouse tissue or 3T3-L1
adipocytes were treated for 15 min to 1 hr in four vol-
umes (w/v) of 0.3SPBSTA (0.3 M Sucrose, 20 mM
KH2PO4, 20 mM Na2HPO4, pH = 7.2, 137 mM NaCl,
3.0 mM KCl, 0.1 % Triton X 100, 0.1 % sodium azide),
plus 3.7 % freshly added formalin. Tissue was washed
twice with phosphate buffered saline. Tissue samples
(100 to 200 mg) were homogenized by hand in a 1.5 ml
microfuge tube with a plastic pestle for 1 min in 6
volumes of 0.3SPBSTA. The homogenate was filtered
through small pieces (5x5 cm sq) of Miracloth (Calbio-
chem, #475855) suspended loosely over a small funnel.
This prevented nuclei from being trapped with large
pieces of cytoplasm during the subsequent centrifuga-
tion and increased the yield of nuclei several fold. Nuclei
were centrifuged through a sucrose cushion (1.4 M
sucrose, in 1.4SPBSTA) in a swinging bucket rotor in a
refrigerated centrifuge (4 °C) at 3,000xg for 15 min. The
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nuclear pellet was gently re-suspended in 10 volumes of
0.3 M SPBSTA Microscopic assays using differential
interference phase microscopy (DIC) combined with
DAPI staining for DNA suggested that the nuclei were
approximately 80 % pure, relative to visible debris that
did not stain with DAPI (Additional file 8: Figure S7).
All reagents were purchased from Thermo Fisher
(Waltham, MA), unless stated otherwise.
Immuno-capture of nuclei
Anti-RFP, anti-FLAG, anti-CD4, anti-CD8, anti-mRFP1
antibodies were coupled to 2.8 micron diameter protein
G supraparamagnetic Dynabeads (ThermoFischer Scien-
tific, #10004D). Bead protocols including the coupling
were handled as per the manufacturer’s instructions.
Briefly, antibody coupled beads were incubated with
nuclei prepared from SUN1mRFP1Flag nucleofected
mice and differentiated 3T3-L1 adipocytes and washed
extensively to remove uncaptured nuclei. The first
uncaptured fraction was assayed in parallel. During the
wash steps the bead-bound nuclei were repeatedly pulled
to the side of 1.5 ml microcentrifuge tubes for 1 min
using neodymium magnets (DynaMag™-2 Magnet rack,
#12321D, ThermoFischer Scientific).
Assays of nuclear transcript levels
Relative quantities (RQ) of nuclear RNA levels from
whole VAT, SAT, and BAT tissue, total isolated nuclei,
captured and uncaptured nuclei were quantified with
qRT-PCR assays. The RQ of transcripts were calculated
based on the dCT method including the standard devi-
ation from the mean (Livak and Schmittgen, 2001).
Primers are listed in Additional file 9: Table S1. SDHA
mRNA was used as the endogenous control to calculate
RQ, because in repeated assays its levels, based on cycle
threshold values (CTs), varied less than 1- to 1.8-fold
relative to input cDNA among various samples of cap-
tured and uncaptured nuclear cDNA preparations, simi-
lar to what we described for fractionated brain cellular
nuclei [56]. Based on CT values, 18S rRNA and beta-
actin [57] were also reasonably equivalently expressed
among cDNA samples and would have been reasonable
endogenous controls, but their CT values varied slightly
more than SDHA among nuclear RNA samples.
RNA from fresh or formalin fixed nuclei was prepared
using an RNeasy FFPE kit (Qiagen #73504). If formalin
treated nuclei were used, a heat treatment of 90 °C for
1 h was included, after the proteinase K digestion in
PKD buffer to hydrolyze off the formalin [56]. The heat-
accelerated hydrolysis of formalin crosslinks is well
established (Fraenkel-Conrat and Olcott, 1948). RNA
was quantified using a Qubit RNA Assay Kit (Life Tech-
nologies, #Q32855). The yield of RNA from 100,000
fixed sorted nuclei varied from 0.5 to 1 μg. 500 ng
samples of RNA were reverse transcribed (RT) into
cDNA using qScript cDNA SuperMix (Quanta BioSci-
ences, #95048). After RT,0.5 μl of RNase H at 5 units/μl
(New England Biolabs, #M0297S) was added to the 20 μl
reaction and incubated at 37 °C for 20 min. cDNA yield
was quantified using the Qubit ssDNA (single strand
DNA Assay Kit #Q10212). 5 ng of cDNA was used per re-
action in qRT-PCR assays. Primers are described in Add-
itional file 9: Table S1. Each assay was run in triplicate and
the standard error calculated to give the error bars shown.
Three biological replicates gave similar results.
Statistical analysis
The mean ± standard error of the mean (SEM) is pre-
sented for various bar graph data. The qRT-PCR data
were further analyzed by one-way ANOVA with post
hoc Tukey’s HSD test using Statistica software 6.1 (Stat-
Soft; Tulsa, OK, USA). Noteworthy statistical compari-
sons are indicted in the figures with * for p < 0.05, ** for
p < 0.01, and *** for p < 0.001 and some p values are also
stated in the text.
Results
A mature-adipocyte-specific expression vector
Adiponectin (ADIPOQ) is one of the most abundant
adipose-tissue derived hormones and has multiple anti-
metabolic and anti-inflammatory properties [58]. ADI-
POQ is expressed in MAs from SAT and VAT and a
subset of non-thermogenic adipocytes from BAT, but is
not significantly expressed in other adipose tissue-
derived cell types including endothelial cells, leukocytes,
and preadipocytes [59–61]. ADIPOQ is expressed in a
few other cell types in the brain [62] that will not affect
our targeting of MAs for capture from adipose tissue.
ADIPOQ promoter driven transcript expression is more
specific for MAs than is expression from the promoters
of two other commonly used marker genes expressed in
adipocytes PPARg and FABP4 [63]. Therefore, we used
an ADIPOQ promoter to express INTACT constructs
that might tag MAs.
We engineered an mouse adiponectin promoter
(ADNp) expression vector (ADNppcDNA3.1) based on
a truncated 5.4 kb version of the full length promoter
reported previously to retain its adipocyte cell-type
specificity [63]. ADNp was incorporated into the back-
bone of the commonly used expression vector
pcDNA3.1 (NeoR) (Materials and Methods, Additional
file 1: Figure S1). To test the specificity and transcrip-
tional activity of this vector, we inserted the coding
sequence (CDS) of a red fluorescent protein, mRFP1,
to make a ADNp::mRFP1 reporter (Additional file 2:
Figure S2) [64]. Assaying red fluorescent protein (RFP)
avoids the low level of endogenous green fluorescence
observed in some adipose tissues. Relative to other
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RFPs, mRFP1 has the advantages of a modestly high
fluorescence extinction coefficient and a rapid protein
maturation rate. Furthermore, mRFP1 does not form a
multimeric cytoplasmic aggregate as do many other
fluorescent proteins, which might interfere with its ef-
ficient localization to the nuclear membrane.
ADNp::mRFP1 was nucleofected into 3T3-L1 preadi-
pocytes. After 6 days of G418 selection for the linked
neomycin resistance marker NeoR, cells were transferred
to adipocyte differentiation medium. No red fluores-
cence was observed in nucleofected preadipocytes dur-
ing cellular expansion prior to differentiation. mRFP1
fluorescence was detected in some cells 3 or 4 days after
initiating differentiation and red fluorescence was very
strong in many clusters of cells by 5 to 7 days (Table 1).
We did not observe an obvious change in overall fluor-
escence intensity even after 14 days, except that cells
filled with oil bodies showed little fluorescence. As
shown in Fig. 2a, mRFP1 fluorescence was observed sur-
rounding newly formed oil bodies within MAs. Hence,
the ADNp promoter in ADNppcDNA3.1 exhibited suffi-
cient specificity and strength to warrant its use in tag-
ging MA nuclei.
Screening nuclear targeted fusion proteins for an effective
INTACT construct
Little is known about the expression and molecular con-
formation of nuclear transmembrane proteins specific
for MAs. Therefore, we tested the ability of portions of
three nuclear transmembrane proteins that have been
characterized in other cell types and organisms, SUN1,
Nesprin 3, and RANGAP1, to target fluorescent
reporters to the surface of adipocytes. Four distinct con-
structs based on these three genes were cloned into the
multi-linker in ADNppcDNA3.1, replacing the mRFP1
gene in ADNp::mRFP1 (Table 1, Additional file 3: Figure
S3, Additional file 4: Figure S4, Additional file 5: Figure
S5, Additional file 6: Figure S6).
3T3-L1 preadipocyte cultures were nucleofected with
each construct, subjected to neomycyin G418 selection
and expansion for 6 days, and then differentiated into
MAs. Live cells in culture dishes were screened by fluor-
escence microscopy for mRFP1 red or GFP green fluor-
escence associated with each construct. No fluorescence
was detected prior to differentiation for any of the con-
structs, confirming again that the 5.4 kb ADNp pro-
moter utilized was not leaky in preadipocytes. While all
reporters fluorescently tagged MA nuclei, they varied
widely in both the timing of first detection and the
strength of nuclear fluorescence (Table 1). SUN1mRFP1-
Flag and Nesp3mRFP1Nesp proteins were both detected
by day 7, after initiating differentiation, but the red fluor-
escence from the SUN1 based construct was consider-
ably stronger than for the Nesprin 3 based construct. It
took a few more days before we first visualized the red
and green fluorescent reporters associated with the
Nesp3mRFP1 or RANGAP1GFP constructs, respectively.
Figure 2c shows a field of differentiated 3T3-L1 adipo-
cytes nucleofected with ADNp::SUN1mRFP1Flag and
photographed for the red fluorescence of mRFP1 portion
of the fusion protein, green fluorescence of neutral lipids
stained with Lipotox Green, and the blue fluorescence of
DNA stained with DAPI. Nucleofection of 3T3-L1 prea-
dipocytes is very efficient and after a few days of G418
enrichment for transfected preadipocytes nearly every
nucleus in the field (~90 %) of MAs showed associated
mRFP1 expression. We found the red fluorescence of
nuclei from SUN1mRFP1Flag was not symmetrically dis-
tributed over the surface of nuclei and was often skewed
to one side relative to DAPI staining of DNA (Fig. 2b).
Based on these promising results we focused on the
ADNp::SUN1mRFP1Flag construct.
Capture of adipocyte nuclei
The asymmetric distribution of the nuclear tag should
not confound our ability to capture nuclei. Nuclei were
purified from mature 3T3-L1 adipocytes 14 days after
initiating the differentiation following the protocol out-
lined in Additional file 8: Figure S7A. Figure 2d shows
nuclei captured with anti-RFP rabbit pAb antibody
coupled to protein G paramagnetic Dynabeads. Nearly
all the mature 3T3-L1 adipocyte nuclei were captured. A
Table 1 Four constructs were tested for fluorescent reporter expression during the differentiation of 3T3-L1 preadipocytes
aADNp::promoted reporter protein Day 4 Day 5 Day 6 Day 7 Day 10 Day 14
mRFP1 + ++ +++ +++ +++ +++
SUN1mRFP1Flag ND ND ND + +++ +++
Nesp3mRFP1 ND ND ND ND ND +
Nesp3mRFP1Nesp ND ND ND + ++ ++
RANGAP1GFP ND ND ND ND + ++
ND not detected. Standard
aThe time (days) after induction to differentiate into MAs when the fluorescent protein was detected is indicated. Preadipocytes were nucleofected with five
adiponectin promoted reporters, one for cytoplasmic expression (mRFP1) to test the vector pADNpcDNA3.1 KanR and four others targeting nuclei and designed
to implement INTACT technology
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negative control performed with Anti-CD4 antibody did
not capture a significant number of nuclei (Fig. 2e), nor
did other unrelated antibodies. Subsequent assays with
commercial anti-Flag mouse monoclonal antibody and
anti-mRFP1 rabbit polyclonal antibodies prepared later
for this study both efficiently captured tagged 3T3-L1
adipocyte nuclei (not shown). Although the efficiency of
capture was not quantified in detail, we did not detect
any obvious difference in the capture with the three
antigen tag-specific antibodies tested (anti-GFP, anti-
mRFP1, anti-Flag), suggesting that the nuclear immuno-
capture technology is relatively robust.
Capturing MA nuclei from transgenic MA-INTACT mice
MA-INTACT transgenic C57BL/6 mice were generated
expressing the ADNp::SUN1mRFP1Flag transgene and
the SUN1mRFP1Flag reporter in VAT, SAT, and BAT
(see Materials and Methods). Two independent lines of
mice, MA-INTACT-C and MA-INTACT-D derived
from independent transformation events were devel-
oped. The C and D lines were indistinguishable from
C57BL/6 mice in size and longevity. The breeding of
these lines is described in Additional file 7: Figure S8.
Three- to four-month-old MA-INTACT mice were
sacrificed. Retroperitoneal (RP) and epididymal (EP)
VAT, inguinal SAT, and scapular BAT (Fig. 3) were
harvested. The tissues were immediately fixed in forma-
lin to preserve chromatin structures, and nuclei were
prepared as described in Materials and Methods and
Additional file 8: Figure S7. Combined DIC and fluores-
cence microscopy of DAPI stained nuclei show these
nuclear preparations were relatively free of contamin-
ation with cell debris (Figure S7C). Furthermore,
Western blots immunostained for histone H3 showed
that nuclei prepared from BAT, SAT, and VAT were
highly enriched for this nuclear protein, relative to the
amount of H3 in total protein extracts from these three
tissues (Figure S7D).
The reporter tagged subsets of MA nuclei (MVA,
MSA, and MBA) nuclei were captured using anti-
mRFP1 rabbit polyclonal antibody pre-bound to protein
G Dynabeads (Fig. 3b-e). The Western immune-blot
probed with antibody to mRFP1 in Fig. 3f shows that
131 kDa SUN1mRFP1Flag fusion protein was associated
with captured MA nuclei in mouse VAT, SAT, and BAT,
but not with uncaptured nuclei. It appears a small amount
of approximately 25 kDa mRFP1-immunoreactive protein
the same size as mRFP1 itself (Right side of blot) may have
been released by proteolytic degredation. Yields of nuclei
from tissue and captured nuclei from 3-month-old mice
are reported in Table 2. In repeated experiments approxi-
mately 45 %, 50 %, and 64 % of the total nuclei were cap-
tured from SAT, VAT, and BAT, respectively (Table 2).
Similar proportions of adipocyte nuclei were captured
from 7-month-old mice.
Gene expression in captured SAT and VAT nuclei
We quantified transcript levels in cDNA prepared from
nuclear RNA from SAT and VAT using qRT-PCR ana-
lysis. It is worth mentioning at this point that nuclear
transcript levels strongly correlate with cytoplasmic
mRNA levels for the vast majority of transcripts [28].
Transcripts enriched in adipocyte and non-adipocyte cell
types in SAT and VAT
The full names of marker transcripts are given in Abbre-
viations. SDHA was determined to be nearly equivalently
expressed among captured (MSA, MVA) and uncaptured
(Uncap) SAT and VAT nuclear RNA preparations based
on equivalent cDNA input into qRT-PCR reactions, and
therefore, SDHA was used as the endogenous control
and set to one in calculations of Relative Quantity (see
Materials and Methods. The RP and EP VAT RNA prep-
arations from individual mice were combined to increase
the amount of VAT RNA and simplify the analysis.
While few marker transcripts are absolutely specific for
a single cell type, transcripts expected to be highly
enriched in mature white adipocytes relative to preadi-
pocytes, leukocytes and/or endothelial cells were assayed
first. Captured MSA and/or MVA nuclei expressed 10-
to 10,000-fold higher levels of ADIPOQ, PPARg2, FABP4,
LEP, and EDNRB transcripts, relative to Uncap-SAT and
Uncap-VAT nuclei (Fig. 4a, p < 0.01 or 0.001). FABP4 is
expressed at low levels in leukocytes [65]. Therefore,
FABP4 expression in uncaptured leukocyte nuclei may
account for this marker transcript being the least
(See figure on previous page.)
Fig. 2 Expression of reporters and capture SUN1mRFP1Flag tagged nuclei from mature 3T3-L1 adipocytes. a Six days after ADNp::mRFP1 nucleo-
fected 3T3-L1 preadipocytes were induced to differentiate into MAs strong cytoplasmic fluorescence of the mRFP1 reporter was detected (see
Table 1, Additional file 2: Figure S2). Pre-adipocytes did not have detectable fluorescence. This result shows the promoter vector was specifically
expressed in MAs. b mRFP1 fluorescence from the ADNp::SUN1mRFP1Flag reporter on the surface of differentiated 3T3-L1 nuclei selected from c.
c Expression of the ADNp::SUN1mRFP1Flag reporter in MAs 10 days after induction of nucleofected 3T3-L1 preadipocytes (DAPI stained DNA (blue),
lipid rich oil droplets detected with Lipotox Green (green), enhanced red fluorescent protein mRFP1 (red). The lower right hand panel shows the
merged fluorescence image. mRFP1 fluorescence is associated with the nuclei. It should be noted that spherical oil droplets often produce an optical
distortion of adjacent nuclei. d Adipocyte nuclei from mature 3T3-L1 cells expressing the SUN1mRFP1Flag reporter were captured with Protein-G Dyna-
beads (2.8 μm diameter) pre-adsorbed with anti-GFP antibody. e A negative control capture performed in parallel using Protein-G Dynabeads pre-
adsorbed with anti-CD4 T cell specific antibody did not capture nuclei
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Fig. 3 Mature MA-INTACT mouse adipocyte nuclei expressed SUN1mRFP1Flag RNA in BAT, VAT, and SAT allowing adipocyte nuclei to be captured
on Immuno-paramagnetic beads. a Illustration of mouse fat deposits examined. b, c, d, e. Nuclei were efficiently captured from crude nuclear
preparations prepared from inguinal SAT (b) retroperitioneal VAT (c) epididymal VAT (d) and scapular BAT (e). Protein G Dynabeads pre-adsorbed
to rabbit anti-mRFP1 polyclonal antibody were used in these capture experiments. The clumping of nuclei occurs during successive rounds of
washing and capture. Negative control antibodies did not capture significant numbers of nuclei (not shown). f A Western blot (top panel) showed
that preparations of captured VAT, SAT, and BAT nuclei expressed the 131 kDa SUN1mRFP1Flag reporter protein, while uncaptured nuclei did not.
In house prepared anti-mRFP1 rabbit pAb detected the mRFP1 domain. Purified 25 kDa mRFP1 was run as a positive control. A loading control
(bottom panel) showed the approximately equal loading of nuclear proteins and an mRFP1 standard. The loading control samples were run for a
short time (20 min) on an SDS PAGE system and protein front stained with Coomassie
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enriched in the captured adipocyte nuclei. Transcripts
encoding the adipocyte marker FAM132A (adipolin)
were significantly (p < 0.001) more highly expressed in
Cap-VAT nuclei than Uncap-VAT, but there was no dif-
ference between the two fractions of SAT nuclei (Fig. 4b).
Hence, it appears that nuclear capture, based on expres-
sion of the SUN1mRFP1Flag reporter, efficiently en-
riches for MA nuclei. Second, transcripts with specificity
for non-adipocyte cell types were assayed. Uncap VAT
and/or Uncap-SAT expressed 2- to 100-fold higher
levels of transcripts encoding most factors with speci-
ficity for leukocytes (IKZF1, RETN, ILF3), endothelial
cells (RETN, SERPINE1 (PAI1), SERPINF1 (PEDF),
TNFA, CD144), and progenitor cells (CD34, KLF2)
relative to the levels in Cap-MSA and Cap-MVA
nuclei (Fig. 4b, c, d). The majority of these differences
were statistically significant (p < 0.01 or p < 0.001). In
short, the Uncap-SAT and -VAT nuclear fractions
appear to represent the expected enrichment of a mix-
ture of non-adipocyte cell types. However, inconsistent
with these data, the endothelial marker transcripts ET1,
VEGFA and CD144, the leukocyte marker IFL3, and the
progenitor cell markers IHH and KLF2 were found at
2- to 10-fold higher levels in Cap-MVA nuclear
fraction rather than Uncap-VAT fraction (p < 0.05 to
p < 0.001).
Distinctions between captured MSA and MVA nuclei
Comparsions of the SAT and VAT transcriptomes from
normal and/or obese subjects reveal the coexpression of
approximately 90 % of transcripts identified and distinct
expression of a remaining substantial subset [10, 66, 67].
We found that captured adipocyte nuclei from VAT and
SAT (MVA and MSA nuclei) expressed similar levels of
31 of the 39 transcripts we assayed, but significantly dif-
ferentially expressed the other eight (e.g., CEBPA, ILF3,
KLF2, RETN, SERPINF1, SERPINE1, TDG, TNFA) (Figs. 4
and 5). CEBPA, KLF2, RETN, SERPINE1 and TNFA have
reported activities particular to adipocytes or obesity-
related diseases. CEBPA is a transcription factor that as-
sists with the differentiation of adipocytes [68]. We
found 40 % lower levels of CEBPA in MVA than MSA
nuclei (p < 0.001), similar to the results reported in a
comparison of VAT and SAT mRNAs in relatively
healthy obese men [66]. This same previous study
showed higher levels of VEGF and LEP in VAT than
SAT, but we did not observe such differences between
MVA and MSA nuclear RNAs. KLF2 acts to suppress
adipogenesis [69]. Thus, the two-fold higher levels of
KLF2 we found in MVA nuclei relative to MSA nuclei
(p < 0.01) may reduce the relative levels of adipogenesis
in VAT. TNFA is a cytokine secreted by macrophages
linked to insulin resistance and diabetes that is also
known to activate preadipocyte genes and inhibit adipo-
genesis [70, 71]. Most studies examine adipocytes
exposed to exogenous TNFA, yet we observed substan-
tial expression of endogenous TNFA transcripts in both
MVA and MSA nuclei. Further, MVAs expressed several
times more TNFA than MSAs (p < 0.01), again favoring
reduced adipogenesis in VAT. Hence, differences in
CEBPA, KLF2 and TNFA transcripts all favor reduced
adipogenesis VAT relative to SAT. We likely detected
and resolved the differential expression of these genes
between MSAs and MVAs, because their expression
levels were not assayed among the transcripts in mixture
of other adipose tissue cell types [10, 66, 67].
A few other transcripts differentially expressed in
MVAs and MSAs may be linked to obesity health risk.
Serum levels of the adipokine RETN (resistin) positively
correlate with mortality risk from diabetes and cardio-
vascular disease [72, 73]. Captured MVA nuclei
expressed 40-fold higher levels of RETN transcripts than
MSA nuclei (p < 0.001). Serpins are protease inhibitors
that unfold and lead to the degradation of their target
proteases, and hence, play important roles in inflamma-
tion and cell death. A systems biology network analysis
of the plasma proteome expressed in obese diabetic pa-
tients relative to normal healthy subjects found SER-
PINE1 at more central nodes of networks linked to
other proteins with roles in obesity, diabetes, and cardio-
vascular disease, than any other plasma protein [74].
Transcripts for SERPINE1 and its distant sequence
homolog SERPINF1 were 20-fold and five-fold, respect-
ively, more highly expressed in MVA than MSA nuclei
(p < 0.01). These transcript differences support the po-
tential negative health outcome of having excess VAT.
Considering that little is known about the differenti-
ation of white adipocytes into beige adipocytes within
SAT and VAT, we assayed two factors normally associ-
ated the browning of adipose tissue and heat generating
Table 2 Recovery of adipocyte nuclei captured on immuno-paramagnetic beads from VAT, SAT, and BAT dissected from the MA-
INTACT mouse
Tissue Tissue weight (ave.) # nuclei recovered (ave.)/nuclei/mg # adipocyte nuclei captured ave.a/% of total
VAT 370 ±mg 93,000±/251± 41,000/44.8 ± 6 %
SAT 160 ±mg 94,000±/587± 48,000/49.5 ± 3 %
BAT 85 ±mg 44,000±/518± 30,000/63.5 ± 8 %
aStandard errors computed from 5 capture experiments on 5 separate 3-month-old MA-INTACT mice using rabbit anti-mRFP1 polyclonal antibodies on 2.8 micron
protein-G coupled paramagnetic Dynabeads. Similar, results were obtained when anti-RFP and anti-Flag antibodies were used as capture reagents
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activity (Fig. 4e). PRDM16 is a transcription factor es-
sential to brown/beige adipose tissue development and
UCP1 is a nuclear encoded uncoupling protein 1 that
generates heat in the mitochondria of brown and beige
adipocytes. PRDM16 and UCP1 transcripts were signifi-
cantly upregulated (200- to 1,000-fold) in Cap-MSA and
Cap-MVA nuclei compared to uncaptured nuclei (p < 0.01
or 0.001) and 10,000-fold higher than they were expressed
in their parent SAT and VAT tissues (Fig. 4f).
Captured BAT nuclei
SUN1mRFP1Flag tagged nuclei were captured from BATas
shown in Fig. 3f and quantified in Table 2. However, adipo-
nectin (ADIPOQ) expression suppresses the thermogenic
Fig. 4 Expression of cell-type specific transcripts in MA nuclei captured from VAT and SAT. qRT-PCR analysis was performed on cDNA prepared
from captured adipocyte nuclei from VAT (MVA) and SAT (MSA) and uncaptured nuclei (UnCap-VAT and -SAT). Nuclear mRNAs were assayed for
transcripts encoding (a) MA markers, (b, c, d) potential markers for leukocytes, endothelial cells, and progenitor cells, (e) markers of thermogenic
beige/bright adipocytes. f The levels of PRDM16 and UCP1 transcripts in whole VAT and SAT tissue were also assayed. SDHA was used as the
endogenous control as it was nearly equivalently expressed in all samples relative to the amount of input cDNA. Bar graphs show the Mean ±
SEM with p < 0.05 *, p < 0.01 **, p < 0.001 *** indicated for selected comparisons
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program in brown adipocytes [61] and reduces expression
of UCP1, the main uncoupling protein that generates heat
in brown adipocytes. Therefore, the ADIPOQ promoter
driven reporter ADNp::SUNmRFP1Flag is not appropriate
to tag thermogenic brown adipocytes. The results from our
assaying a battery of cell type-specific and function-specific
transcripts by qRT-PCR (Additional file 10: Figure S9) do
not identify the captured nuclei as representing a single
recognizable cell type. As might be expected from
the inverse relationship between ADIPOQ and UCP1,
uncaptured BAT nuclei expressed several fold higher
levels of transcripts encoding UCP1 and APLN[75]
(p < 0.01), when compared to captured BAT adipo-
cyte nuclei. APL is an adipocyte specific hormone
that promotes the metabolic activity of brown
adipocytes [75]. By contrast, captured MBA nuclei
were enriched for some adipocyte enriched marker
transcripts FAM132A (adipolin), LEP [76], PAX3 [77]
RETN, and SERPINF1 [78] (p < 0.05 to 0.001), while
neither nuclear population was enriched for other
transcripts that might be considered adipocyte-
enriched (e.g., PRDM16, PPARg2, FABP4, ZIC1). In
addition, captured BAT nuclei were enriched for
progenitor cell transcripts CD34, GATA2, KLF2, and
IHH (p < 0.05 to 0.01). Finally, and adding to the
complexity of this result, endogenous ADIPOQ tran-
scripts were equivalently expressed in captured and
uncaptured nuclei. We speculate that the ADIPOQ
promoter driven reporter tagged multiple cell types
in BAT.
Fig. 5 Expression of transcripts encoding chromatin remodeling factors in MA nuclei captured from VAT and SAT. a Transcripts encoding
chromatin-remodeling proteins involved in the turnover cycle for DNA cytosine modification. b Transcripts encoding chromatin-remodeling
proteins involved in nucleosomal histone modification and movement. For details see Fig. 4
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Transcripts encoding chromatin remodeling proteins
We assayed transcript encoding two classes of chroma-
tin remodeling factors. First, we examined mRNAs for
factors involved in the cycle of DNA cytosine modifica-
tion and turnover, because of their role in adipogenesis.
DNA cytosine methylation in preadipocytes during the
contact inhibition stage of growth appears essential to
licensing their ability to differentiate at a later stage into
mature lipid containing adipocytes [79]. During the exe-
cution of adipogenesis cytosine demethylation of
PPARg2 promoter is essential for PPARg2 expression
[80]. By contrast, the gene for the bromodomain sup-
pressor of adipogenesis BDR2 becomes increasingly
methylated and silenced during adipogenesis [81]. Our
analysis included two DNA cytosine methyltransferases
DNMT1 and DNMT3A that methylate cytosine (C) to 5-
methylctosine (5mC), three 5mC dioxygenases (TET1, 2,
3) that oxidize 5mC to 5-hydroxymethylcytosine (5hmC)
and subsequently to more oxidized forms (5caC and
5fC), thymine glycosylase TDG that removes 5caC and
5fC to generate an abasic site, and repair enzymes
GADD45A and GADD45B that restore C residues to the
abasic sites (Fig. 5a). TET2, TET3, TDG, GADD45A and
GADD45B transcripts were at higher levels in Cap-MVA
nuclei than Uncap-VAT nuclei (p < 0.05 to 0.01). The
encoded proteins are all involved in removal of 5mC and
cycling back to C, suggesting that the cycle of cytosine
modification might run faster in VAT-derived adipo-
cytes. In contrast, TET2, TDG, DNMT1, and GADD45A
transcripts were at higher levels in Uncap-SAT than
Cap-MSA nuclei (p < 0.05 to 0001). TDG (thymine DNA
deglycosidase) participates in the turnover of DNA 5´-
methylcytosine and in the repair of DNA in terminally
differentiated cells. TDG is expressed in human adipose
tissue derived mesenchymal stem cells and [82]. Its 4-
fold higher expression in MVA than MSA nuclei might
represent regulatory or repair functions. In short the
transcript expression for factors involved in cytosine
modification and turnover are distinctly differentially
expressed in SAT- and VAT-derived nuclear populations,
which should impact adipogenesis.
Second, we examined factors involved histone and nu-
cleosome remodeling, focusing on the posttranslational
modification of histone side chain lysine and arginine
residues (Fig. 5b), because of their roles in adipogenesis
[83–85]. Transcripts encoding the lysine acetyltransfer-
ase KAT2B and lysine demethylase KDM4 are expressed
at 100- to 1,000-fold higher levels in Uncap-SAT and
-VAT nuclei than in the captured fractions. Transcripts
for the protein arginine methyltransferase PRMT1 were
expressed at 8- to 10-fold higher levels in Uncap-SAT
and Uncap-VAT nuclei than in captured. Two other
PRMTs, CARM1 (PRMT4) and PRMT5 were 2- to 3-
fold more weakly expressed in Uncap-SAT nuclei than
in the other three nuclear fractions. Transcripts for
PAXP1 which controls chromatin condensation and
gene activation and ARID1A (BAF250) a ATP-dependent
swi/snf remodeler were 3- to 50-fold more highly
expressed in Uncap-SAT and -VAT nuclei than Cap-
MSA or Cap-MVA nuclei. In total, the generally higher
expression of these transcripts in non-adipocyte nuclei
suggest that the non-adipocyte cell types may be turning
over the classes of chromatin structures controlled by
these remodeling activities faster than adipocytes.
Discussion
MAs from SAT and VAT
Mature adipocyte nuclei expressing the SUN1mRFP1-
Flag reporter were easily captured from SAT and VAT
dissected from the MA-INTACT mouse. Most tran-
script markers of specific for SAT and VAT MAs
were expressed at three orders-of-magnitude higher
levels in the captured nuclei relative to uncaptured
nuclei. This demonstrates not only the exceptional
purity of captured nuclei, but also the efficiency of
capture, because few nuclei with these activities
appear to be left behind in the uncaptured fraction.
Similarly, most transcripts specific to leukocyte,
endothelial, and progenitor cells were significantly
enriched in the uncaptured nuclear fraction. VAT and
SAT are relatively distinct in their developmental ori-
gins, in their metabolic and gene expression profiles,
and in their contribution to obesity related disease
[4–10, 86]. So perhaps it is not surprising that a few
transcripts considered markers of adipocytes or non-
adipocytes were found significantly enriched in the
captured MVAs as compared to the uncaptured VAT
and/or captured MSA nuclei. We found captured,
MVAs expressed significantly higher levels of TNFA,
CEBPA, and KLF2 transcripts than MSA, all of which
favor reduced levels of adipogenesis in VAT and
higher levels of RETN and SERPINs, which are linked
to obesity-related disease risk. Most of these differ-
ences between VAT and SAT have not been reported
previously, presumably due to the power of examining
mature adipocyte nuclei enriched away from other
adipose tissue cell types. As additional explanations
for transcripts being unexpectedly enriched in the
MVA fractions we suggest: (1) MAs isolated from
within their in vivo environment may have heretofore
unknown properties distinct from adipocytes matured
in silico and/or (2) nuclear RNA levels do not repre-
sent cytoplasmic RNA levels for a small percent of
transcripts [28].
By contrast, both captured and uncaptured nuclei
from BAT were slightly but significantly enriched for
some classes of marker transcripts, but they expressed
the same levels of endogenous ADIPOQ transcripts. We
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anticipated that the ADIPOQ promoter driven reporter
would not tag thermogenic adipocyte nuclei [61], but in
any case, a large percentage of BAT nuclei were cap-
tured (Table 2). Our data suggest that expression of the
ADNp::SUNmRFP1Flag reporter is not cell type specific
in BAT. Perhaps endogenous transcription factors and/
or transgene position effects alter reporter expression in
BAT, problems that do not appear to impact reporter
specificity in VAT or SAT.
White adipocyte-derived beige/bright adipocytes within
white adipose tissue may behave as thermogenic adipo-
cytes and express PRDM16, a high level transcriptional
co-regulator of brown adipocyte development, and the
heat generating uncoupling protein UCP1 [21, 87, 88].
However, it was surprising to find the captured MSA and
MVA nuclei expressed such exceptionally high levels of
nuclear transcripts encoding PRDM16 and UCP1, three
orders of magnitude above the levels in non-adipocyte nu-
clei and above that observed in the adipose tissues them-
selves and above the endogenous control SDHA. It is
unlikely that there were enough of the beige adipocytes
enriched in the MSA and MVA nuclear fractions to ac-
count for such high transcript levels. Further, ADIPOQ
expression is known to suppress UCP1 expression in
brown adipocytes [61]. An alternative explanation is that
these two transcripts are exceptions to the rule about
nuclear transcript levels correlating with cytoplasmic
transcripts levels. In the founding paper on INTACT
technology [28], there was a strong linear correlation
between nuclear and cytoplasmic mRNA levels with
an r value of 0.94. In other words, only a small frac-
tion of transcripts do not fit this relationship. Yet,
PRDM16 and UCP1 transcripts could belong to this
subset, and be much more highly expressed in the
nucleoplasm than the cytoplasm. If these transcripts
remain in the nucleus in most tissue-derived adipo-
cytes, they would not be expressed as protein. If this
is the case, then nuclear RNA transport may be an
important factor controlling UCP1 and PRDM16 ex-
pression in adipocytes. The ongoing transcription and
nuclear accumulation of thermogenic transcripts in
MAs might create a poised decondensed chromatin
state enabling white adipocytes to more rapidly
develop into beige adipocytes upon cold induction
[89, 90].
Chromatin remodeling factors in SAT- and VAT-derived
adipocytes
Because adipocytes are the defining cell type in adi-
pose tissue, we had considered the following hypoth-
esis: adipocytes isolated from VAT and SAT express
higher levels of transcripts for chromatin remodeling
factors than supporting cell types, perhaps making
them more responsive to environmental stimuli. We
examined factors involved in DNA cytosine modifica-
tion and nucleosomal histone side chain modification
that could be involved in controlling adipogenesis or
maintenance of MAs.
DNA cytosine modification in adipose tissue
The development of lipid body-rich MAs proceeds
after preadipocytes leave the cell cycle [79] and a com-
plex role for DNA methylation-based gene silencing
by has been implicated in this process. Global DNA
cytosine methylation levels increase, two days after the
differentiation of 3 T3-L1 cells begins [79]. Within the
first 24 h of differentiation, expression of the mainten-
ance DNA methyltransferase DNMT1 increases sig-
nificantly [91]. Once MAs have developed DNMT1
levels decrease. The de novo cytosine methyltransfer-
ase DNMT3A may also play a positive role, because
siRNA silencing of DNMT3A in 3 T3-LI preadipoctyes
significantly blocks adipogenesis [79]. When a cytidine
analog and inhibitor of both DNMTs 5-azacytidine (5-
azaC) is used to treat bone marrow derived MSCs, a
normal precursor of adipocytes, there is a decrease in
precursor cell proliferation and adipogenesis [92].
Similarly, treating atrial cardiac cells with 5-azaC leads
to the trans-differentiation into lipid body-containing
adipocytes [93]. In contrast to these experimental re-
sults suggesting a simple positive role for methylation,
siRNA silencing of DNMT1 in preadipocytes acceler-
ates adipogenesis [91]. To understand the role of DNA
methylation it is useful to place these results in a lar-
ger context. DNA cytosine modification at critical
gene region CG dinucleotides proceeds via a complex
cycle of methylation to 5mC by DNMTs, oxidation to
5hmC and beyond by TETs, and base excision and re-
pair by TDG, GADD45s, and additional factors. Al-
though steady state levels and gene region distribution of
5mC often appear constant within a cell type, the turnover
rate of 5mC has been shown to be quite rapid when mea-
sured. Half lives of less than 30 min are not uncommon
[94]. Any step in the cycle might be differentially regulated
in a particular cell type. Therefore we thought it would be
informative to assay representative factors spanning the
cytosine modification cycle. Although it is true that we
found differential expression of 7 of the 8 factors assayed
among one or more of the captured adipocyte nuclei or
uncaptured non-adipocyte nuclear fractions, the results
do not support our working hypothesis. As particular ex-
amples, TDG, DNMT1, and GADD45A transcripts are
much more highly expressed in uncaptured non-adipocyte
SAT nuclei than in MSA nuclei. Only TET3, TDG, and
GADD45A were more highly expressed in MVA nuclei
than uncaptured non-adipocyte VAT nuclei fitting the pre-
diction from our hypothesis.
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Nucleosomal histone modification
We examined the expression of transcripts encoding
several nucleosomal histone remodeling factors with
presumed roles in adipogenesis or maintenance of
adipocytes.
Very early in the differentiation of 3T3-L1 preadipo-
cytes levels of histone 3 lysine 9 methylation (H3K9me3)
increase 2- to 3-fold, enabling preadiopcytes to differen-
tiate into MAs [79]. SETDB1 and KDM4 regulate the
levels of histone methylation (e.g., H3K9me1, me2,
me3). SETDB1 methylates H3K9 and H3K9me1 to
H3K9me3, a modification associated with transcriptional
repression [95]. PPARg is a high-level regulator of adipo-
genesis, fatty acid storage and glucose metabolism. Via
its modifying activity SETDB1 represses PPARg transac-
tivation at target genes. In opposition to SETDB1,
KDM4A/JMJD2A is a lysine-specific demethylase that
directly demethylates H3K9me3 to H3K9me1/2 [96, 97].
KDM4A is essential to recruiting PPARg to its target
genes expressed during adipocyte development [98]. The
levels of SETDB1 were not distinct among the nuclear
fractions. Somewhat surprising, we found order of mag-
nitude higher levels of KDM4 in the two uncaptured
SAT and VAT nuclear populations, relative to levels the
captured MSA and MVA fractions. Again these data are
contrary to our working hypothesis.
We examined the transcript levels of three histone argin-
ine methyltransferases (PRMTs), PRMT1, CARM1 (PRMT4)
and PRMT5. Among their multiple activities these three
PRMTs can methylate four arginine residues on the N-
terminus of histone H3 and one on H4 and these modifica-
tions are generally associated with gene activation. PRMT4
and PRMT5 appear to play positive roles in adipogenesis by
supporting PPARg expression [85, 99–101]. PRMT1 is the
dominant type I PRMT and has an essential role in cell
proliferation and genome maintenance [102] and de-
fects in PRMT1 are associated with cardiovascular dis-
ease [103, 104]. However, specific roles for PRMT1 in
preadipoctyes, MAs, or adipogenesis are yet to be de-
scribed. We found PRMT1 was several fold more highly
expressed in VATand SAT non-adipocyte nuclei, than in cap-
tured MSA or MVA nuclei. This may not be surprising
considering that PRMT1 appears to be important for the
mesenchymal-epithelial transition, which might impact the
endothelial cell population. The levels of CARM1 and PRMT5
transcripts fit expectation, at least in part, because their levels
were a few-fold higher in captured MSA nuclei than in uncap-
tured SAT nuclei. ARID1A (BAF250) is the well-studied ATP-
dependent swi/snf subunit of several nucleosome remodeling
complexes. ARID1A transcripts were dramatically more highly
expressed in the uncaptured fractions.
In summary, among captured MSA and/or MVA nuclei
and uncaptured nuclei, there were distinct differences in
the expression levels of 10 of the 16 transcripts examined.
However, the results do not support the hypothesis
being tested. In fact, for a significant majority of
comparisons between captured MSAs and MVAs and
their uncaptured counterparts, the uncaptured nuclei
expressed higher levels of the chromatin remodelers
assayed. Considering the evidence for the high degree
of purity of captured MA nuclei, it is unlikely that
our results reflect any significant contamination of
the captured and uncaptured fractions from SAT or
VAT. Although a simple interpretation is not obvious,
these results do suggest that the supporting cell types
within SAT and VAT are more active in chromatin re-
modeling than MAs.
Conclusions
Epigenetics is the study of cell-type specific differences in
chromatin structure within an organ or tissue develop-
mental context. To improve cell-type specific analyses of
adipocytes we engineered two populations of inbred MA-
INTACT mice in which the surface of MA ADIPOQ ex-
pressing nuclei are tagged. This enabled the efficient
immunocapture of MSA and MVA nuclei from within
VATand SAT, separating them from the nuclei of contam-
inating endothelial, leukocyte, progenitor, and preadipo-
cyte nuclear types. Transcript for classical adipocyte
markers were enriched in the captured nuclei by several
orders of magnitude, confirming the high levels of purity
of MSA and MVA nuclei. Captured and uncaptured nu-
clei, however, had some novel and unexpected properties.
For example, MSA and MVA nuclei expressed high levels
of transcripts for two markers of thermogenic beige or
brown adipocytes. In addition, the uncaptured populations
often expressed higher levels of transcripts encoding chro-
matin remodeling factors assayed, relative to captured adi-
pocyte nuclei. These data do not support our working
hypothesis that adipocytes would be the most epigeneti-
cally active cell type in adipose tissue.
MA-INTACT mice may be used to monitor epige-
nomic, transcriptomic, and proteomic changes in iso-
lated MA nuclei from VAT and SAT and perhaps other
tissues that we have not yet examined such as adipocytes
within bone and muscle. Our long-term goal was to
enable studies on the impact of various environmental
influences such as aging, diet, exercise, stress, and drug
treatment on adipocytes. The reporter transgene
ADNp::SUN1mRFP1Flag could be recombined with
model mice designed to examine obesity-related diseases
in which adipocytes may play direct or indirect roles
such as metabolic syndrome, cardiovascular disease,
some cancers, Alzheimer’s, and diabetes.
The D line of MA-INTACT mice, homozygous for the
ADNp::SUN1mRFP1Flag transgene (Additional file 7:
Figure S8D) and will be made available for distribution
after publication of this manuscript.
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Additional files
Additional file 1: Figure S1. Structure of the ADIPOQ expression vector
pADNpcDNA3.1 KanR. The indicated multilinker contains a BspLU11l site
(5´-ACATGT) containing the ATG initiation codon and the down stream
NheI site forming the replacement region used in the molecular cloning
of five reporter protein coding sequences. (PDF 1382 kb)
Additional file 2: Figure S2. Structure of the ADNp::mRFP1 reporter
vector in which the CDS of mRFP1 was cloned into the BspLU11l – NheI
replacement region of pADNpcDNA3.1. This reporter was used to test the
specificity of expression from the ADIPOQ expression cassette. The
untethered mRFP1 is expressed in the cytoplasm. (PDF 1382 kb)
Additional file 3: Figure S3. Structure of the INTACT reporter vector
pADNp::SUN1mRFP1Flag. The mRFP1Flag CDS was inserted into the
BspLU11l – NheI replacement region of pADNpcDNA3.1. This was the
most powerful reporter construct and was used in most applications
described in the manuscript. (PDF 1382 kb)
Additional file 4: Figure S4. Structure of the INTACT reporter
ADNp::mRFP1Nesp. The mRFP1Nesp CDS was inserted into the BspLU11l –
NheI replacement region of pADNpcDNA3.1. This construct was set aside,
after initial screening in 3 T3-L1 derived adipocytes. (PDF 1382 kb)
Additional file 5: Figure S5. Structure of the INTACT reporter
ADNp::NespmRFP1Nesp. The NespmRFP1Nesp CDS was inserted into the
BspLU11l – NheI replacement region pADNpcDNA3.1. This construct was
set aside, after initial screening in 3 T3-L1 derived adipocytes. (PDF
1382 kb)
Additional file 6: Figure S6. Structure of the INTACT reporter
ADNp::RANGAP1GFP-BLRP. The RANGAP1GFP-BLRP CDS was inserted into
the BspLU11l – NheI replacement region pf pADNpcDNA3.1. BspLU11L
and NheI sites were added to the RanGap1-GFP-BLRP gene described in
Deal & Henikoff [28] by mutagenic PCR. This construct was set aside, after
initial screening in 3 T3-L1 derived adipocytes. (PDF 1382 kb)
Additional file 7: Figure S8. Breeding of transgenic mouse lines #0023C
(C line) and #0025D (D line) expressing the ADNp::SUN1mRFP1Flag construct.
A. Litter Progression from Founder #0023 (C line). B. Litter Progression from
Founder #25 (D-line). C & D. Monitoring transgene expression during
backrosses of C and D line to WT. Relative Quantity of transgene (RQ) from
qPCR screening of the first generation of selfing of F2 generation offspring to
obtain homozygous lines for the ADNp::SUN1mRFP1Flag transgene. An
mRFP1 gene primer pair was used (mRFP Additional file 9: Table S1). CT values
were normalized to qPCR values for actin gene ACTB using the dCT method
[105] to obtain a relative quantity of gene copies (1x hets, 2x homo, ~0 WT).
D. Notice the constant 2x RQ level of mRFP1 qPCR product when inbreeding
homozygous lines. (PDF 1382 kb)
Additional file 8: Figure S7. Enrichment protocol for SAT, VAT, and
BAT cellular nuclei images showing relative purity. A. Adipose tissue
depots examined. B. Summary of protocol for isolating nuclei prior to
capture. C. Image of enriched nuclei from VAT, SAT, and BAT. This is a
combined image with DIC in green and DAPI DNA fluorescence in red.
D. The protein was extracted from tissue and from enriched nuclear
preparations, resolved by PAGE-SDS on a 15 % gel run for 1 hr and
15 min at 20 ma and examined for the levels of nuclear protein histone
H3 on an immunoblot (anti-H3 mouse monoclonal ab10799). The signal
was developed using HRP-conjugated goat anti-mouse antibody
(NA931V) and a ECL kit (RPN2106) for detection. Parallel samples were
run for 15 min on a duplicate gel and the protein front was stained for
total protein with Coomassie blue to show approximately equal loading
among paired samples. (PDF 1382 kb)
Additional file 9: Table S1. Oligonucleotide primers used during
qRT-PCR of transcripts and qPCR of ADNp::SUN1mRFP1Flag transgene.
(PDF 1382 kb)
Additional file 10: Figure S9. Expression of cell-type- and function-
specific transcripts in MA nuclei captured from BAT. qRT-PCR analysis
was performed on cDNA prepared from captured adipocyte nuclei
from BAT (MBA) and uncaptured nuclei (UnCap-BAT). Nuclear mRNAs
were assayed for transcripts encoding (A-F) Cell-type and function
markers. SDHA was used as the endogenous control as it was nearly
equivalently expressed in captured and uncaptured samples relative
to the amount of input cDNA. Bar graphs show the Mean ± SEM with
p < 0.05 *, p < 0.01 **, p < 0.001 *** indicated for selected comparisons.
(PDF 1382 kb)
Abbreviations
ADIPOQ, adiponectin; APLN, Apelin; ARID1A (BAF250, SWI-SNF-related AT
Rich Interactive Domain 1A); CARM1, PRMT4, Coactivator-Associated Arginine
Methyltransferase 1; CEBPA, CCAAT/Enhancer Binding Protein (C/EBP), Alpha;
CD144/CDH5, VCAD, Cadherin 5; DNMT1 and DNMT3A, DNA Cytosine-5´-
Methyltransferase 1 and 3A; EDNRB, Endothelin receptor type B; ET1, ET-1,
Endothelin 1; FABP4, adipocyte protein 2, aP2, FABP4, fatty acid binding
protein 4; FAM132A, Adpl, Adipolin, Adipose-Derived Insulin-Sensitizing
Factor; GADD45A B, Growth Arrest And DNA-Damage-Inducible, Alpha, Beta;
GATA2, endothelial transcription factor GATA Binding Protein 2; IKZF1, Ikaros
family zinc finger protein 1; KAT2C, MLL3, KMT2C, Lysine-Specific
Methyltransferase 2C; KDM4A, H3K9/36me3 lysine-specific demethylases 4A,
JMJD2A Jumonji Domain Containing 2A; IHH, Indian Hedgehog Homolog),
IKZF1 (IKAROS family zinc finger protein 1; ILF3, interleukin enhancing binding
factor 3; KLF2, zinc finger transcription factor Kruppel-Like Factor 2; LEP, leptin,
obesity factor, obesity homolog; SERPINE1, PAI1, Plasminogen activator
inhibitor-1; PCAM1, Platelet/Endothelial Cell Adhesion Molecule 1; PPARg2,
adipocyte specific 2nd isoform of peroxisome proliferator-activated receptor
gamma; PRDM16, PR domain containing 16; PRMT1 and PRMT5, protein arginine
methyltransferase 4 and 5; PAXIP1/PTIP, PAX Interacting with Transcription-
Activation Domain Protein 1, promotes histone H3 lysine 4 methylation; RETN,
Resistin, C/EBP-Epsilon-Regulated Myeloid-Specific Secreted Cysteine-Rich Protein;
SDHA, Succinate dehydrogenase complex subunit A; SERPINE1, PAI1, Endothelial
Plasminogen Activator Inhibitor; SERPINF1, PEDF, Pigment epithelium-derived
factor; SETDB1/KMT1E, SET Domain Bifurcated 1, Histone H3-K9 Methyltransferase
4; SREBF1, sterol regulatory element binding transcription factor 1; TDG, G/T
Mismatch-Specific Thymine DNA Glycosylase; TET1, 2, 3, Ten-Eleven Translocation-
1, 2, 3, Tet Methylcytosine Dioxygenase, TNFA, tumor necrosis factor alpha, UCP1,
uncoupling protein 1; VEGFA, Vascular Endothelial Growth Factor A; ADSC, adipose
tissue derived stem cell; DFAT, dedifferentiated adipocyte-derived progeny
cell; INTACT, Isolation of Nuclei Tagged in specific Cell Types; MA, mature
adipocyte; VAT, SAT, BAT, visceral, subcutaneous, and brown adipose tissue,
respectively; MVAs MSAs MBAs, mature adipocytes from VAT, SAT, and BAT,
respectively; qRT-PCR, quantitative real-time polymerase chain reaction
amplification of cDNA
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